Skip to main content

Table 1 Characteristics of participants

From: “Am I gonna get in trouble for acknowledging my will to be safe?”: Identifying the experiences of young sexual minority men and substance use in the context of an opioid overdose crisis

Participants

50

Age (average, range)

24.18 (18–30 years)

Ethnicity1

White

26 (52%)

Aboriginal2

10 (20%)

Latin American

7 (14%)

South Asian

5 (10%)

Southeast Asian

2 (4%)

Chinese

2 (4%)

Korean

2 (4%)

Filipino

2 (4%)

Arab/West Asian

2 (4%)

Black

1 (2%)

Japanese

1 (2%)

Other

2 (4%)

Gender3

Cisgender man

44 (88%)

Transgender man

4 (8%)

Queer

4 (8%)

Genderqueer

2 (4%)

Non-binary

1 (2%)

Sexual orientation3

Gay

29 (58%)

Bisexual

14 (28%)

Pansexual

6 (12%)

Queer

4 (8%)

Straight

2 (4%)

Asexual

1 (2%)

Unsure

1 (2%)

Other (incl. homoflexible)

2 (4%)

Opioid use

Non-opioid substance use

Both opioid and non-opioid substance use4

40 (80%)

10 (20%)

Substances used in the previous 12 months

Alcohol

47 (94%)

Cannabis

41 (82%)

MDMA

25 (50%)

Cocaine

20 (40%)

Poppers

20 (40%)

Mushrooms

20 (40%)

Meth

18 (36%)

Benzodiazepines

Ketamine

11 (22%)

11 (22%)

Erectile dysfunction drugs

10 (20%)

GHB

9 (18%)

Speed

9 (18%)

T3s5

7 (14%)

Crack

5 (10%)

Heroin

5 (10%)

Fentanyl

4 (8%)

Opioids6

4 (8%)

LSD

4 (8%)

Methadone

3 (6%)

Steroids

3 (6%)

Ritalin

1 (2%)

Others7

8 (16%)

  1. 1Some participants selected more than one ethnicity
  2. 2Although our sociodemographic survey included the term “Aboriginal,” which refers to the First Nations, Inuit, and Métis peoples, as defined by the Constitution Act of 1982, this term has traditionally been used in a generic sense and in legal contexts [53]. In this paper, we use the term “Indigenous,” which refers to first peoples internationally
  3. 3Some participants selected more than one gender identity and/or sexual orientation
  4. 4All participants who reported using opioids engaged in polysubstance use that included non-opioid substances
  5. 5T3s (Tylenol #3) contain acetaminophen, caffeine, and codeine
  6. 6Other physician-prescribed opioids than those listed here
  7. 7Other substances used by participants included: Prozac, Concerta, Adderall, Dexedrine, Methadrone, MxP, 2CE, and 2CC, 2C-T-7, 2C-B, 5-Me0-DMT, nn-DMT, 4-AcE-DMT, allylescaline, nitrous oxide (whippets)